Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine cream for rosacea
IRCT20190901044666N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of cyclosporine in Erythematotelangiectatic Rosacea (ETR) and papulopustular rosacea, sponsored by Iran University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
cyclosporine
03
Conditions
Erythematotelangiectatic Rosacea (ETR)papulopustular rosacea
Beyond the preview
Go deeper on IRCT20190901044666N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190901044666N2.